(Q36544021)

14 August 2017

title

Clinical experience with anticonvulsant medication in pediatric epilepsy and comorbid bipolar spectrum disorder (English)

1 reference

14 August 2017

1 reference

Jay A Salpekar

1

1 reference

14 August 2017

Joan A Conry

2

1 reference

14 August 2017

Wright Doss

3

1 reference

14 August 2017

Sandra Cushner-Weinstein

4

1 reference

14 August 2017

Phillip L Pearl

5

1 reference

14 August 2017

Steven L Weinstein

6

1 reference

14 August 2017

William D Gaillard

7

1 reference

14 August 2017

publication date

24 July 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

9

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

327-334

1 reference

Behavioral disorders in pediatric epilepsy: unmet psychiatric need

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Symptoms of depression and anxiety in pediatric epilepsy patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Symptoms of depression in adolescents with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Is major depression a neurologic disorder with psychiatric symptoms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Social competence in pediatric epilepsy: insights into underlying mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Psychopathology in pediatric complex partial and primary generalized epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Screening for major depression in epilepsy with common self-report depression inventories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Depression and anxiety disorders in pediatric epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

When did neurologists and psychiatrists stop talking to each other?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Defining clinical phenotypes of juvenile mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Manic episode in epilepsy and bipolar I disorder: a comparative analysis of 13 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Depression in Epilepsy Is Much More Than a Reactive Process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Interictal behavior abnormality in temporal lobe epilepsy. A specific syndrome or nonspecific psychopathology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Interictal behavior syndrome in temporal lobe epilepsy: the views of three experts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Postictal mania associated with frontal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

A history of the use of anticonvulsants as mood stabilizers in the last two decades of the 20th century.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Lamotrigine in psychiatry: pharmacology and therapeutics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Divalproex sodium in the treatment of pediatric psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Depression and mania in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Current status of the utilization of antiepileptic treatments in mood, anxiety and aggression: drugs and devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Lamotrigine and antiepileptic drugs as mood stabilizers in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

The clinical use of gabapentin in bipolar spectrum disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Nonepileptic uses of gabapentin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Monotherapy treatment of bipolar disorder with levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Use of topiramate in treatment-resistant bipolar spectrum disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Tiagabine in treatment refractory bipolar disorder: a clinical case series.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Open-label adjunctive zonisamide in the treatment of bipolar disorders: a prospective trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

A Preliminary Open-Label Study of Zonisamide Treatment for Bipolar Depression in 10 Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Tiagabine in the Management of Postencephalitic Epilepsy and Impulse Control Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Carbamazepine in the treatment of aggression: a case report and a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Varieties of aggressive behavior in temporal lobe epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Psychopharmacologic treatment of pathologic aggression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Cognitive and behavioral effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Phenomenology of depression in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Levetiracetam psychosis in children with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Catatonia induced by levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Behavioural effects of the newer antiepileptic drugs: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Treatment of comorbid bipolar disorder and epilepsy with valproate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Neuropsychological and behavioral abnormalities in an adolescent with frontal lobe seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Behavioural effects of the new anticonvulsants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Neurobiology of seizures and behavioral abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Neurochemical underpinnings in bipolar disorder and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Kindling models and antikindling effects of mood normalizers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Does kindling model anything clinically relevant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Mechanisms of action of antiepileptic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Mood effects of antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Antiepileptic drugs and neuroprotection: current status and future roles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Preliminary observations on the effectiveness of levetiracetam in the open adjunctive treatment of refractory bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2006.06.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2006.06.004

1 reference

14 August 2017

1 reference